Connect with us

Technology

NanoImaging Services Acquires Proteos, Enhancing Integrated Protein Sciences and Structure-Based Discovery Capabilities

Published

on

SAN DIEGO, Jan. 6, 2025 /PRNewswire/ — NanoImaging Services (“NIS”), the leading provider of cryo-electron microscopy (“cryo-EM”) services for drug discovery and development, is excited to announce the acquisition of Proteos, Inc. (“Proteos”), a contract research organization (CRO) specializing in high-quality protein production services for discovery research. Headquartered in Kalamazoo, Michigan and founded in 2003, Proteos offers comprehensive recombinant protein and antibody expression, purification, and analysis services in support of both small and large life-science customers. This strategic acquisition joins Proteos’ expertise in protein production with NIS’s market-leading cryo-EM solutions, creating an integrated offering for customers seeking structure-based drug discovery and protein production services.

John Rigg, CEO of NIS, commented, “We are delighted to welcome the Proteos team to the NIS family and are incredibly excited to solidify the Company’s unwavering commitment to cutting edge science and service excellence. This union further establishes NIS as a market leader in structure-based drug discovery and enables us to combine upstream protein expression with cutting edge downstream analysis and cryo-EM imaging to best meet the evolving needs of current and future customers.”

“We are pleased to have found a strong partner in NIS that is similarly customer-focused and scientifically driven, and we see a perfect fit between the companies’ protein production and cryo-EM capabilities,” said Proteos CEO Mary Shuck. “Importantly, this partnership will provide Proteos with additional resources to enhance our services and solutions for our customers. We are thrilled to join forces with NIS to advance innovation and excellence in structural biology, setting a new standard in the industry.”

Backed by Ampersand Capital Partners, a global investment firm with offices in Boston and Amsterdam, NIS has become an industry leader in providing cryo-EM services for drug discovery and nanoparticle characterization. Ampersand General Partner David Parker adds, “Bringing NIS and Proteos together is a major step forward in our efforts to meet the rapidly evolving demands of the drug discovery market utilizing structure-based approaches and novel computational models. Whether a customer wants help producing a target protein, screening therapeutic candidates, or generating data to power a computer-aided drug discovery approach, NIS can now provide a one-stop-shop for their needs.”

About NanoImaging Services
NanoImaging Services, Inc. was launched in 2007 to provide imaging services to the pharmaceutical, biotechnology, and nanotechnology communities, and has since built a client-focused organization with a reputation for expertise, reliability, and collaboration. NIS’ state-of-the-art facilities include a range of electron microscopes, sample preparation equipment, and computational infrastructure to support structural biology and nanoparticle characterization workflows. NIS is the largest and most comprehensive provider of TEM and cryo-EM services to the industrial life science market. For more information, visit: www.nanoimagingservices.com.

About Proteos, Inc.
Headquartered in Kalamazoo, MI, Proteos is a trusted partner to the biotechnology industry, specializing in the production of high-quality data and recombinant proteins to facilitate discovery research. With a focus on supporting exploratory research, and supported by a highly-tenured team, Proteos has established itself as a leader in the sector. For more information, visit: www.proteos.com.

About Ampersand Capital Partners
Ampersand Capital Partners, founded in 1988, is a middle-market private equity firm with $3 billion of assets under management, dedicated to growth-oriented investments in the healthcare sector. With offices in Boston, MA, and Amsterdam, Netherlands, Ampersand leverages a unique blend of private equity and operating experience to build value and drive long-term performance alongside its portfolio company management teams. Ampersand has helped build numerous market-leading companies across each of the firm’s core healthcare sectors. For additional information, visit AmpersandCapital.com or follow us on LinkedIn.

View original content to download multimedia:https://www.prnewswire.com/news-releases/nanoimaging-services-acquires-proteos-enhancing-integrated-protein-sciences-and-structure-based-discovery-capabilities-302342484.html

SOURCE NanoImaging Services

Continue Reading

Technology

commercetools Named a Leader in 2026 Gartner® Magic Quadrant™ for Digital Commerce as AI Reshapes the Market

Published

on

By

commercetools is a Leader in the 2026 Gartner® Magic Quadrant™ for Digital Commerce for the seventh consecutive year.commercetools has been driving AI innovation on how enterprises build, operate and sell, including capabilities like Sphere, Commerce MCP and commercetools for Builders.commercetools is helping global enterprises modernize complex commerce operations and prepare for a future where both people and AI agents discover, shop and transact.

BOSTON, Oct. 22, 2026 /PRNewswire/ — commercetools, the digital commerce AI company, today announced it has been positioned as a Leader in the 2026 Gartner® Magic Quadrant™ for Digital Commerce. This marks the seventh consecutive year commercetools has been recognized as a Leader in the report.

As AI reshapes commerce, commercetools is expanding how it supports the enterprises who build and operate commerce experiences, and the shoppers who use them. Global enterprises including JD Sports, Nederlandse Spoorwegen, Chemist Warehouse and Mirion Technologies are using commercetools to modernize complex digital commerce, accelerate growth and adopt new AI-powered ways of operating and selling.

“Commerce is moving from systems that simply respond to human instructions toward systems that can increasingly understand, decide and act,” said Doug McNary, Chief Executive Officer at commercetools. “We’re proud to be named a Leader for the seventh consecutive year. Enterprises shouldn’t have to choose between the flexibility they need today and the autonomy they’ll need tomorrow. Our focus is giving them the technology to support both.”

Over the past year, commercetools has introduced new products and capabilities designed to bring AI across the commerce lifecycle:

Sphere: Brings together commercetools’ AI-native infrastructure and agent governance through Commerce MCP into a unified platform for enterprises to build, operate and sell with AI.commercetools for Builders: Helps anyone build, extend and evolve enterprise commerce faster with AI.AgentSphere: Lets enterprises build and manage AI agents to run commerce operations and agentic shopping, with appropriate guardrails to do so safely and at scale.Modular commerce offerings: Gives enterprises the flexibility to start with the capabilities they need and expand over time, accelerating time to value without requiring a full commerce transformation upfront.Commerce Integration Layer: Centralizes integration logic behind customer-facing experiences. Storefronts, mobile apps and AI agents connect through a unified layer hosted and maintained by commercetools.Smart Data Modeler: Uses AI to accelerate product data modeling, helping teams build the right foundation faster and reduce time-to-launch.

commercetools’ customers include large enterprises across retail, manufacturing, life sciences, healthcare and telecommunications in markets around the world.

To learn more about commercetools’ position as a Leader, download your complimentary copy of the 2026 Gartner Magic Quadrant report today.

About the Gartner Magic Quadrant for Digital Commerce

Gartner, Magic Quadrant for Digital Commerce Platforms, Aditya Vasudevan, Penny Gillespie, Sandy Shen, Jason Daigler, Mike Lowndes, 19 October 2026

Gartner and Magic Quadrant are trademarks of Gartner, Inc., and/or its affiliates.

Gartner does not endorse any company, vendor, product or service depicted in its publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner publications consist of the opinions of Gartner’s business and technology insights organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this publication, including any warranties of merchantability or fitness for a particular purpose.

About commercetools

commercetools, the global digital commerce AI company, helps enterprises transform commerce for the AI era. Built API-native from the start and AI-first by design, our technology enables agentic shopping experiences, automates commerce operations and gives businesses the agility to modernize faster, innovate continuously and operate more intelligently.

More than 500 global brands, retailers and enterprise companies rely on commercetools to power their digital commerce. Together, they process more than $100 billion in annualized GMV, over 700 million orders and more than one billion customer records on our platform.

Media Contact: comms@commercetools.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/commercetools-named-a-leader-in-2026-gartner-magic-quadrant-for-digital-commerce-as-ai-reshapes-the-market-302916761.html

SOURCE commercetools

Continue Reading

Technology

Phylo’s Biomni Lab to expand the use of AI agents in scientific research at Bayer

Published

on

By

SOUTH SAN FRANCISCO, Calif., Oct. 22, 2026 /PRNewswire/ — Phylo, Inc. announced today a partnership with Bayer to deploy Biomni Lab, Phylo’s agentic AI platform to accelerate scientific research and evaluation. 

Under the agreement, Phylo will provide Bayer with full access to its agentic platform that helps Bayer scientists bring together scientific literature, biomedical data, and analytical methods in one environment, reducing the manual effort required to assemble and assess evidence. The platform’s inspectable workflows preserve the context behind each result, allowing researchers to review the underlying sources, methods, and execution and apply their own scientific judgment. Bayer scientists will gain access to Biomni Lab for workflows focused on assembling literature and omics evidence for drug discovery.

“This partnership reflects our belief that AI should expand scientific curiosity, not just speed up routine work. Giving our scientists an AI partner that brings rigor to every step lets them explore more ideas, ask bolder questions, and find the insights that move drug discovery forward, ultimately accelerating the pace at which we can bring new medicines to patients,” said Sai Jasti, Senior Vice President, Head of Data Science & Artificial Intelligence, Bayer Pharmaceuticals R&D.

“For agentic AI to matter in research, it has to earn the trust of the scientists doing the work. Bayer’s selection of Biomni Lab is a strong endorsement of the scientific rigor and AI capabilities we’ve built into the platform,” said Kexin Huang, Ph.D., Co-Founder and CEO of Phylo. “Our vision is an AI-native operating system for biopharma, where every scientist can direct a team of AI agents to pursue complex research questions. With Bayer, we aim to show what becomes possible when AI capabilities meet deep scientific expertise: more hypotheses explored, more discoveries made, and new possibilities for medicine.”

About Phylo

Phylo’s mission is to bring the best agentic intelligence to every biomedical scientist. Its enterprise-grade AI platform, Biomni Lab, is the first Integrated Biology Environment—a unified workspace where scientists collaborate with AI agents across literature research, experimental design, biological data analysis, and scientific decision-making.

Biomni Lab is now used by leading global biopharma, including Bayer, Chugai Pharmaceutical and Ono Pharmaceutical. Phylo is based in South San Francisco, backed by Andreessen Horowitz (a16z) and Menlo Ventures.

For more information, visit phylo.bio. To learn more about Biomni Lab, visit biomni.phylo.bio.

View original content to download multimedia:https://www.prnewswire.com/news-releases/phylos-biomni-lab-to-expand-the-use-of-ai-agents-in-scientific-research-at-bayer-302917080.html

SOURCE Phylo, Inc.

Continue Reading

Technology

Sandler Partners Welcomes Bryan Rias as Director, Sales Engineer, West Region

Published

on

By

New Hire Announcement | Independent Technology Distributor Sandler Partners grows its Sales Engineering team, adding Bryan Rias as Director, Sales Engineer, West Region.

REDONDO BEACH, Calif., Oct. 22, 2026 /PRNewswire/ — Sandler Partners, the leading independent Technology Solutions Distributor, announces the addition of Bryan Rias as Director, Sales Engineer, West Region, further strengthening its dedicated sales engineering team and the technical support available to Partners in the West Region.

Bryan brings more than two decades of experience designing and delivering complex technology solutions, including enterprise and Cloud architecture roles at Lumen/Savvis and IBM focused on infrastructure modernization and customer success. His expertise spans automation, edge computing, disaster recovery, application performance monitoring (APM), and DevSecOps. In his role, Bryan will support Partners across the West Region, aligning early with them on strategy and leading thoughtful discovery to help them find the right fit for each client.

For Bryan, strong relationships and solid values guide his life and form the foundation of his professional success, a perspective that fits naturally within the Sandler Partners community. When he is not working, Bryan spends time with his family, including his wife, three sons, and a grandson, RVing, boating, and biking, along with pursuing his passion for freediving.

“Bryan brings the kind of hands-on experience our Partners value: he’s been in the room on complex deals and knows how to turn a customer’s needs into the right solution,” says Justin Marano, Chief Revenue Officer, Sandler Partners. “He came to Sandler for the freedom to work across best-of-breed Providers, and our Partners in the West will feel that right away. He’s collaborative, grounded, and focused on helping Partners win. I’m excited to have him on the team.”

“I’m excited to get to work alongside our Partners, helping them navigate complex opportunities and bring clarity to technical decisions,” says Bryan. “For me, it all comes back to relationships. When you build them on trust and shared values, the results follow for our Partners and their clients. That’s something that the Sandler community really embodies, and I look forward to getting to work with our Partners!”

About Sandler Partners
Sandler Partners helps empower its network of leading independent Sales Partners to deliver a comprehensive range of technology solutions to organizations worldwide, including Cybersecurity, Artificial Intelligence (AI), Connectivity, Cloud, Colocation, Mobility, Internet of Things (IoT), and Continuity. Its community-focused approach enables Partners to identify the right solutions for customers quickly and objectively from a diverse portfolio of 220+ Providers. Partner sales agents, VARs, and MSPs gain access to an innovative suite of sales tools within the Sandler Portal—including SCOUT, Solutions Finder, Scout for Solutions, and the Marketing Center—several of which are AI-powered, all backed by a robust support network, dedicated Sales Engineering expertise, and rich marketing resources. Together, these tools and resources empower Partners to focus on what they do best: delivering quality, value, performance, innovative solutions, unmatched expertise, and exceptional service to their clients. Members of the Sandler Partners community also benefit from the industry’s strongest negotiated agreements and a dedicated team committed to ensuring commissions are accurately identified, tracked, and paid. For more information, visit www.sandlerpartners.com.

Sandler Partners – Media Contact
Tina S. Dyksterhouse
tina@sandlerpartners.com
310-861-2295

View original content to download multimedia:https://www.prnewswire.com/news-releases/sandler-partners-welcomes-bryan-rias-as-director-sales-engineer-west-region-302916413.html

SOURCE Sandler Partners

Continue Reading

Trending